Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Watanabe

Showing results (251-260 of 295) with videos related to

Pageof 30
Sort By:
The Journal of Biological Chemistry|June 15, 2011
Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetesSusumu Mitsutake, Kota Zama, Hazuki Yokota, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2014
Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiencyAkifumi Endo, Ken Watanabe, Tamae Ohye, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 2, 2018
Decreased Psoas Muscle Computed Tomography Value Predicts Poor Outcome in Peripheral Artery DiseaseTakayuki Sugai, Tetsu Watanabe, Yoichiro Otaki, et al.
Clinical Journal of Gastroenterology|July 18, 2015
Mesenteric lymph node abscess due to Yersinia enterocolitica: case report and review of the literatureKen Watanabe, Noboru Watanabe, Mario Jin, et al.
Scientific Reports|August 11, 2017
Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responsesTakehiko Yamanashi, Masaaki Iwata, Naho Kamiya, et al.
Heart and Vessels|December 31, 2017
The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failureTetsuya Takahashi, Tetsu Watanabe, Tetsuro Shishido, et al.
Leukemia & Lymphoma|September 17, 2014
Toxic encephalopathy after exposure to azacitidineKen Watanabe, Noriko Doki, Yoshiharu Miura, et al.
Internal Medicine (Tokyo, Japan)|February 16, 2016
Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid LeukemiaShuhei Kurosawa, Noriko Doki, Yutaro Hino, et al.
Hypertension (Dallas, Tex. : 1979)|November 2, 2020
HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling PathwayJun Goto, Yoichiro Otaki, Tetsu Watanabe, et al.
Neuropsychopharmacology Reports|March 4, 2020
Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depressionNaofumi Kajitani, Masaaki Iwata, Akihiko Miura, et al.
Pageof 30

Showing results (251-260 of 295) with videos related to

Sort By:
Pageof 30
The Journal of Biological Chemistry|June 15, 2011
Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetesSusumu Mitsutake, Kota Zama, Hazuki Yokota, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2014
Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiencyAkifumi Endo, Ken Watanabe, Tamae Ohye, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 2, 2018
Decreased Psoas Muscle Computed Tomography Value Predicts Poor Outcome in Peripheral Artery DiseaseTakayuki Sugai, Tetsu Watanabe, Yoichiro Otaki, et al.
Clinical Journal of Gastroenterology|July 18, 2015
Mesenteric lymph node abscess due to Yersinia enterocolitica: case report and review of the literatureKen Watanabe, Noboru Watanabe, Mario Jin, et al.
Scientific Reports|August 11, 2017
Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responsesTakehiko Yamanashi, Masaaki Iwata, Naho Kamiya, et al.
Heart and Vessels|December 31, 2017
The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failureTetsuya Takahashi, Tetsu Watanabe, Tetsuro Shishido, et al.
Leukemia & Lymphoma|September 17, 2014
Toxic encephalopathy after exposure to azacitidineKen Watanabe, Noriko Doki, Yoshiharu Miura, et al.
Internal Medicine (Tokyo, Japan)|February 16, 2016
Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid LeukemiaShuhei Kurosawa, Noriko Doki, Yutaro Hino, et al.
Hypertension (Dallas, Tex. : 1979)|November 2, 2020
HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling PathwayJun Goto, Yoichiro Otaki, Tetsu Watanabe, et al.
Neuropsychopharmacology Reports|March 4, 2020
Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depressionNaofumi Kajitani, Masaaki Iwata, Akihiko Miura, et al.
Pageof 30